An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

NCT00681941 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Hyperphosphatemia

Interventions

DRUG: Sevelamer carbonate (Renvela®)

Sponsor

Genzyme, a Sanofi Company